Last update 23 Jan 2025

SSR-241586

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
NK2R x NK3
Mechanism
NK2R antagonists(Neurokinin 2 receptor antagonists), NK3 antagonists(Neurokinin 3 receptor antagonists)
Therapeutic Areas
Digestive System DisordersOther Diseases
Active Indication-
Inactive Indication
Anxiety DisordersDepressive Disorder, MajorIrritable Bowel Syndrome+ [1]
Originator Organization
SanofiSanofi
Active Organization-
Inactive Organization
SanofiSanofiHoechst Pakistan Ltd.Hoechst Pakistan Ltd.
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC32H42Cl2N4O3
InChIKeyRVQZVVJLIUXDPN-YTTGMZPUSA-N
CAS Registry1239279-30-1

Related

100 Clinical Results associated with SSR-241586
Login to view more data
100 Translational Medicine associated with SSR-241586
Login to view more data
100 Patents (Medical) associated with SSR-241586
Login to view more data
2
Literatures (Medical) associated with SSR-241586
15 Apr 2011The Journal of Organic ChemistryQ2 · CHEMISTRY
Asymmetric Synthesis of an Antagonist of Neurokinin Receptors: SSR 241586
Q2 · CHEMISTRY
20 Aug 2010Organic LettersQ1 · CHEMISTRY
Enantioselective Synthesis of SSR 241586 by Using an Organo-Catalyzed Henry Reaction
Q1 · CHEMISTRY
100 Deals associated with SSR-241586
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Anxiety DisordersPhase 1
FR
Hoechst Pakistan Ltd.Hoechst Pakistan Ltd.
-
Anxiety DisordersPhase 1-
SanofiSanofi
-
Depressive Disorder, MajorPhase 1
FR
Hoechst Pakistan Ltd.Hoechst Pakistan Ltd.
-
Depressive Disorder, MajorPhase 1-
SanofiSanofi
-
Irritable Bowel SyndromePhase 1-
SanofiSanofi
-
Irritable Bowel SyndromePhase 1
FR
Hoechst Pakistan Ltd.Hoechst Pakistan Ltd.
-
SchizophreniaPhase 1
FR
Hoechst Pakistan Ltd.Hoechst Pakistan Ltd.
-
SchizophreniaPhase 1-
SanofiSanofi
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free